bioMérieux S.A. (EPA:BIM)
France
· Delayed Price · Currency is EUR | Market Cap | 14.09B |
| Revenue (ttm) | 3.98B |
| Net Income (ttm) | 432.20M |
| Shares Out | 117.93M |
| EPS (ttm) | 3.64 |
| PE Ratio | 32.83 |
| Forward PE | 26.33 |
| Dividend | 0.90 (0.75%) |
| Ex-Dividend Date | Jun 9, 2025 |
| Volume | 14,412 |
| Average Volume | 116,787 |
| Open | 119.10 |
| Previous Close | 119.50 |
| Day's Range | 118.20 - 120.20 |
| 52-Week Range | 88.25 - 122.50 |
| Beta | 0.48 |
| RSI | 50.95 |
| Earnings Date | Sep 4, 2025 |
About bioMérieux
bioMérieux S.A. develops and markets in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers CHROMID RANGE, a chromogen culture media; RAPIDEC CARBA NP biochemical test for the detection of carbapenemaseproducing bacteria; air, surface, and water monitoring systems; BACT/ALERT VIRTUO BACT/ALERT 3D, a blood sample culture system; BIOFIRE, a multiplex polymerase chain reaction (PCR) system; BIOFIRE SPOTFIRE Lowplex PCR point-of-care system; V... [Read more]
Financial Performance
In 2024, bioMérieux's revenue was 3.98 billion, an increase of 8.31% compared to the previous year's 3.67 billion. Earnings were 432.20 million, an increase of 20.86%.
Financial StatementsNews
bioMérieux S.A. (BMXMF) Q4 2024 Earnings Call Transcript
bioMérieux S.A. (BMXMF) Q2 2024 Earnings Call Transcript
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2021 Results - Earnings Call Transcript
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q3 2021 Results - Earnings Call Transcript
bioMérieux: Pioneering In Vitro Diagnostics
bioMérieux is a leading developer and producer of in vitro diagnostic solutions with a focus on infectious diseases. The Company has a solid financial structure to support growth.
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript
bioMérieux S.A. (BMXMF) CEO Alexandre Mérieux on Q4 2020 Results - Earnings Call Transcript